%0 Generic
%A Trigo, J.
%A Cho, B. C.
%A Park, K.
%A Girard, N.
%A Viteri, S.
%A Garrido, P.
%A Krebs, M. G.
%A Thayu, M.
%A Knoblauch, R. E.
%A Xie, J.
%A Bauml, J. M.
%A Schnepp, R. W.
%A Londhe, A.
%A Mahadevia, P.
%A Leighl, N.
%T Risk and management of intracranial progression on amivantamab in epidermal growth factor receptor (EGFR) exon 20 insertion (ex20ins)-mutated non-small cell lung cancer (NSCLC)
%D 2022
%@ 0923-7534
%U http://hdl.handle.net/10668/21888
%~